The Ministry of Health of Slovakia, in cooperation with the Slovak Society of Pathologists, organized a Presentation Day of Digital Pathology Solutions at Comenius University in Bratislava.
Travere signs $120m licensing deal with Renalys for sparsentan in Asia
Share this article Sparsentan received accelerated approval by the US Food and Drug Administration (FDA) to reduce proteinuria in adults with primary IgA nephropathy. Credit: